Patent Assignment
Reel/Frame 073921/0442
Change of Name
Recorded: 2026-02-27
Pages: 6
Assignor
JUVENTAS CELL THERAPY LTD.
Executed: 2025-11-07
Assignee
JUVENTAS CO., LTD.
BUILDING 5, NO. 8, HAITAI DEVELOPMENT 3RD ROAD, HUAYUAN INDUSTRIAL ZONE, BINHAI HIGH-TECH ZONE, TIANJIN, 300384, CHINA
Covered Properties
(5)
Perfusion Culture Method for Car-T Cells
Application:
18/550,750 →
Publication:
US 2024/0191190
Plasmid Combination and Application Thereof in Preparing Modified Immune Cells
Plasmid Combination and Application Thereof in Preparing Modified Immune Cells
CD19-Targeted Chimeric Antigen Receptor and Use Thereof
CD19-Targeted Chimeric Antigen Receptor and Use Thereof
Application:
18/056,616 →
Publication:
US 2023/0201261
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 26, 2021
From: LIU, YUN; SHI, LIN; LV, LULU; XIE, PAN
To: JUVENTAS CELL THERAPY LTD
Reel/Frame 057301/0701 →
Assignment of Assignor's Interest
Aug 26, 2021
From: WANG, JIANXIANG; WANG, MIN; LV, LULU; SHI, LIN
To: JUVENTAS CELL THERAPY LTD
Reel/Frame 057302/0033 →
Assignment of Assignor's Interest
Sep 18, 2023
From: SHI, LIN; XIE, ZHIMING; YANG, XIAOYAN; JIN, XIA
To: JUVENTAS CELL THERAPY LTD.
Reel/Frame 064934/0482 →
Assignment of Assignor's Interest
Feb 9, 2026
From: LIU, YUN; SHI, LIN; LV, LULU; XIE, PAN
To: JUVENTAS CELL THERAPY LTD.
Reel/Frame 073732/0981 →
Assignment of Assignor's Interest
Feb 9, 2026
From: WANG, JIANXIANG; WANG, MIN; LV, LULU; SHI, LIN
To: JUVENTAS CELL THERAPY LTD.
Reel/Frame 073733/0058 →